Clinical Trials Browser

Gastrointestinal Neoplasms × Erlotinib Hydrochloride × Clear all

NCT04591431 2023-10-03

ROME

Phase 2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

NCT02013089 2016-08-30

GITIC

Phase NA Unknown

Gastrointestinal

Gastrointestinal Neoplasms

NCT00356889 2014-05-28

Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors

Phase 2 Completed

56 enrolled 9 charts

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms